ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,807 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselArakena Pharmaceuticals AG
Arakena Pharmaceuticals AG Logo
Verified· 2 sources

Arakena Pharmaceuticals AG

Summary

About the company

Arakena Pharmaceuticals AG focuses on discovering and developing GRK5 inhibitors as a first‑in‑class treatment for acute and chronic cardiomyopathies, including Takotsubo cardiomyopathy. The company in‑licenses mid‑stage discovery compounds and develops drug‑like, GRK‑selective inhibitors, applying AI‑assisted decision tools and university‑licensed intellectual property to advance preclinical and clinical development.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered3
Development of GRK5 inhibitors
Discovery and development of GRK5 inhibitors as a first-in-class treatment for acute and chronic cardiomyopathies, in particular Takotsubo cardiomyopathy and other heart diseases.
In-licensing of drug candidates
In-licensing of discovery compounds with validated concepts and potential for first-in-class approaches; build a patent-protected asset portfolio with exclusive option-to-license IP.
Preclinical drug development
Preclinical development of PCC-ready compounds with demonstrated efficacy and mechanism of action in disease models as a basis for further preclinical and clinical development.

Knowledge

No knowledge articles yet

Once Arakena Pharmaceuticals AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Arakena Pharmaceuticals AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Arakena Pharmaceuticals AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Arakena Pharmaceuticals AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Beim Buremichelskopf 20
4059 Basel

At a glance

Legal form
Corporation
UID
CHE-351.058.572
Founded
2024 · 2 years
Last commercial register change
November 21, 2025
Employees
1 to 10

Similar companies

SA
Sandoz AG
Basel
SG
Sandoz Group AG
Basel
ET
EraCal Therapeutics AG
Basel
RA
RECORDATI AG
Basel